zonisamide has been researched along with homovanillic acid in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukushima, Y; Hirano, T; Ishida, M; Kaneko, S; Kondo, T; Okada, M; Otani, K | 1 |
| Gluck, MR; Granson, H; Santana, LA; Yahr, MD | 1 |
| Araki, T; Kato, H; Kuroiwa, H; Yano, R; Yokoyama, H | 1 |
| Choudhury, ME; Kubo, M; Nagai, M; Nishikawa, N; Nomoto, M; Yabe, H | 1 |
| Asano, T; Hikawa, R; Takahashi, R; Uemura, MT; Yamakado, H | 1 |
5 other study(ies) available for zonisamide and homovanillic acid
| Article | Year |
|---|---|
Effects of zonisamide on extracellular levels of monoamine and its metabolite, and on Ca2+ dependent dopamine release.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Anticonvulsants; Biogenic Monoamines; Calcium; Chromatography, High Pressure Liquid; Corpus Striatum; Dopamine; Hippocampus; Homovanillic Acid; Isoxazoles; Male; Rats; Rats, Wistar; Zonisamide | 1992 |
Novel dopamine releasing response of an anti-convulsant agent with possible anti-Parkinson's activity.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adrenergic Agents; Animals; Antiparkinson Agents; Behavior, Animal; Carbidopa; Corpus Striatum; Disease Models, Animal; Dopamine; Dopamine Agents; Homovanillic Acid; Isoxazoles; Levodopa; Microdialysis; Oxidopamine; Parkinson Disease; Rats; Zonisamide | 2004 |
A novel anti-Parkinsonian agent, zonisamide, attenuates MPTP-induced neurotoxicity in mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Anticonvulsants; Antiparkinson Agents; Astrocytes; Corpus Striatum; Dopamine; Glial Fibrillary Acidic Protein; Homovanillic Acid; Isoxazoles; Male; Mice; Mice, Inbred C57BL; MPTP Poisoning; Neurons; Neuroprotective Agents; Parkinson Disease; Substantia Nigra; Tyrosine 3-Monooxygenase; Zonisamide | 2009 |
Zonisamide increases dopamine turnover in the striatum of mice and common marmosets treated with MPTP.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Anticonvulsants; Biogenic Amines; Brain Chemistry; Callithrix; Dopamine; Dopamine Agents; Dyskinesia, Drug-Induced; Homovanillic Acid; Isoxazoles; Male; Mice; Mice, Inbred C57BL; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Neostriatum; Neurons; Selegiline; Zonisamide | 2009 |
Zonisamide inhibits monoamine oxidase and enhances motor performance and social activity.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Antiparkinson Agents; Astrocytes; Brain; Dopamine; Exploratory Behavior; Homovanillic Acid; Isoxazoles; Locomotion; Male; Mice, Inbred C57BL; Monoamine Oxidase; Neurons; Parkinson Disease; Social Behavior; Zonisamide | 2017 |